BIO SCIENCE ANIMAL HEALTH |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.42 THB | +8.92% |
|
+4.91% | -30.20% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 2.21B 61.29M | Sales 2023 | 2.43B 67.19M | Capitalization | 1.54B 42.61M |
|---|---|---|---|---|---|
| Net income 2022 | 55M 1.52M | Net income 2023 | 50M 1.38M | EV / Sales 2022 | 1.07 x |
| Net cash position 2022 | 120M 3.31M | Net cash position 2023 | 90.76M 2.51M | EV / Sales 2023 | 0.6 x |
| P/E ratio 2022 |
40.3
x | P/E ratio 2023 |
30.3
x | Employees | - |
| Yield 2022 |
1.54% | Yield 2023 |
2.24% | Free-Float | 15.95% |
More Fundamentals
* Assessed data
More news
| 1 day | +8.92% | ||
| 1 week | +4.91% | ||
| Current month | +2.40% | ||
| 1 month | +8.92% | ||
| 3 months | +4.91% | ||
| 6 months | -25.97% | ||
| Current year | -30.20% |
1 week
3.10
3.60
1 month
3.103.60
Current year
3.044.90
1 year
3.046.55
3 years
3.0413.80
5 years
3.0413.80
10 years
3.0413.80
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 23-08-31 | |
| President | 65 | - | |
Prameth Khamphak
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 20-12-31 | |
| Director/Board Member | - | - | |
| Chief Administrative Officer | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-19 | 3.42 | +8.92% | 1 289 909 |
| 24-05-17 | 3.14 | -1.26% | 229,914 |
| 24-05-16 | 3.18 | -0.63% | 497,700 |
| 24-05-15 | 3.2 | -1.23% | 623,800 |
| 24-05-14 | 3.24 | -0.61% | 180,300 |
End-of-day quote Thailand S.E., May 19, 2024
More quotes
Bioscience Animal Health Public Company Limited (BIS) is a Thailand-based company. The Company is an importer and distributor of medical supplies, tools, equipment and products for livestock and pets. It focuses on selecting products by specialist veterinarians to improve animal health. The Company's products include antibiotic, additive, BiSMiX B-Series, BiSMiX SD Series, injection, mold inhibitor, water-soluble products, and vaccine. The antibiotic includes Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. The injection consists of Zuprevo, Nuflor, Ceva and Enzaprost. Its services include comprehensive farm advisor, disease prevention and surveillance program, serological examination and diagnosis program, biosafety and hygiene management program, analysis of feed raw materials, preparation of feed formulations, feed production inspection and monitoring program, management and upskilling of farm personnel.
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -30.20% | 27.29M | |
| +19.10% | 84.56B | |
| -27.37% | 72.41B | |
| +2.04% | 27.73B | |
| -8.73% | 17.75B | |
| -1.10% | 17.11B | |
| +5.05% | 16.03B | |
| +71.78% | 13.07B | |
| +6.43% | 12.91B | |
| +69.46% | 12.55B |
- Stock Market
- Equities
- BIS Stock
